S. 705: Innovation in Pediatric Drugs Act of 2025

S. 705 is a federal bill in the 119th Congress. Before this bill, drugs designated for rare diseases, known as orphan drugs, were generally exempt from government requirements to study how they work in children. Under this bill, the Food and Drug Administration can now force drug companies to conduct… See its sponsors, how members voted, and a plain-English breakdown on PolityLens.